Items in cart [0] Questions? Call 888-624-8373

PAPERBACK + PDF your price: $43.50 add to cart PAPERBACK list:$37.00 Web:$33.30 add to cart PDF BOOK your price: $28.50 add to cart PDF CHAPTERS your price: $2.90 select Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY PDF Report Brief Display this book on your site! Related Titles Calling the Shots: Immunization Finance Policies and Practices Other Related Titles Financing Vaccines in the 21st Century: Assuring Access and Availability (2003) Board on Health Care Services (HCS) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 235   E-mail  Facebook  Digg  Stumble  Twitter More Page 235 Front Matter (R1-R16) Executive Summary (1-20) 1 Introduction (21-38) 2 Origins and Rationale of Immunization Policy (39-62) 3 Public and Private Insurance Coverage (63-90) 4 Delivery Systems (91-106) 5 Vaccine Supply (107-144) 6 Conclusions and Alternative Strategies (145-182) 7 Recommendations (183-210) References (211-220) Glossary (221-228) Appendix A: Recommended Vaccine Schedules (Childhood and Adult) (229-234) Appendix B: List of Contributors (235-238) Appendix C: Survey of State Vaccine Finace Practices (239-240) Appendix D: Overview of Commissioned Papers (241-242) Appendix E: Commitee and Staff Biographies (243-248)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 235
Appendix B List of Contributors CENTERS FOR DISEASE CONTROL AND PREVENTION NATIONAL IMMUNIZATION PROGRAM Walter Orenstein, Director Lance Rodewald, Associate Director for Science Martin Landry, Associate Director, Planning, Evaluation and Legislation Bill Gallo, Associate Director, Policy Planning and Legislation Achal Bhatt, Program Officer Lawrence Barker, Assessment Branch Mary Ann Bryant, Contracting Officer Margaret Coleman, Economist K.C. Edwards, Program Officer Rex Ellington, Technical Project Officer Lisa Galloway, National Immunization Program Alison Johnson, Deputy Director, Immunization Services Division Laurie Johnson, Deputy Director, Epidemiology and Surveillance Division Sharon Katz, Acting Director, Office of Program Planning and Evaluation Glen Koops, Branch Chief, Program Operations Kimberly Lane, Deputy Associate Director, Management and Operations Robert Linkins, Chief, Systems Development Branch 235

OCR for page 236
236 FINANCING VACCINES IN THE 21ST CENTURY Dean Mason, Chief, Program Support Branch, Immunization Services Division Dennis O'Mara, Associate Director for Adult Immunization Abigail Shefer, Chief, Health Services Research and Evaluation Branch Philip Smith, National Immunization Program Michael Washington, Industrial Engineer, Data Management Division Bruce Weniger, Assistant Chief for Vaccine Development Melinda Wharton, Director, Epidemiology and Surveillance Division OTHER CONTRIBUTORS Mohammad Akhter, American Public Health Association Bud Anthony, Great Falls, VA Harris Berman, Tufts Health Plan Carmella Bocchino, American Association of Health Plans Damian Braga, Aventis Pasteur Kristin Butterfield, American Academy of Pediatrics Boyd Clarke, Neose Technologies Martha Cook, American Academy of Pediatrics Charles Cutler, American Association of Health Plans lean Davis, Director, American Academy of Pediatrics Henry Desmarais, Health Insurance Association of America Gordon Douglas, Princeton, Nr John DuMoulin, American College of Physicians-American Society of Internal Medicine Geoffrey Evans, Health Resources and Services Administration Thomas Fileccia, Department of Defense John Fontenesi, University of California at San Diego David Friend, Watson Wyatt Worldwide Lisa German-Foster, Office of Senator rack Reed Geno Germano, Wyeth-Lederle Barry Gershon, GlaxoSmithKline Jayne Gilbert, Chiron ruliana Gonen, Washington Business Group on Health John Grabenstein, U.S. Army Medical Command Henry Grabowski, Duke University Christine Grant, Aventis Pasteur Robert Gribble, Marshfield Clinic Claire Hannan, Association of State and Territorial Health Officials Maxine Hayes, Washington State Health Department Janet Heinrich, General Accounting Office Karen Hendricks, American Academy of Pediatrics Sarah Henning, Marshfield Clinic

OCR for page 237
APPENDIX B Bill Herman, Highsmith Inc. Susan Hildebrandt, American Association of Family Physicians Linda Hilson, IMS Health, UK Phil Hosbach, Aventis Pasteur William Howell, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD Noreen Hunt, Children's Primary Care Medical Group, San Diego Hejab Imteyaz, Washington, DC rake Jacobs, Capitol Outcomes Research Inc. Scott ranch, American College of Physicians-American Society of Internal Medicine Susan Lanza, Health Insurance Association of America r° Lecouliard, GlaxoSmithKline Greg Lehmann, National Business Coalition on Health Susan Lett, Massachusetts Department of Health Barbara Levine, Association of State and Territorial Health Officials Richard Levinson, American Public Health Association Clement Lewin, Chiron roan Mahanes, Centers for Medicare and Medicaid Services Adel Mahmoud, Merck Vaccine Division Henri Manasse, American Society of Health System Pharmacists Eugene Mascolo, Aventis Pasteur Mark Mathew, Parexel International Corporation Brian McKenna, Aventis Pasteur Patrick McLean, GlaxoSmithKline Suzanne Mercure, National Business Coalition on Health rack Meyer, Economic and Social Research Institute Allen Meyerhoff, Capitol Outcomes Research Inc. Kent Moore, American Association of Family Physicians Jessica Mullan, Office of Senator Richard Durbin Thomas Musco, Health Insurance Association of America Karen Nielsen, GlaxoSmithKline Jackie Noyes, American Academy of Pediatrics Ryan O'Connor, American Medical Group Association Peter Paradiso, Wyeth-Lederle Frank Pasquire, General Accounting Office rim Pawelski American Academy of Pediatrics Steve Pearlin, Geisinger Clinic Dean Perry, Geisinger Clinic Joe Piascentini, U.S. Department of Labor Chris Queram, Employer Healthcare Alliance Cooperative Sarah Radcliff, Pharmaceutical Research and Manufacturers Association Bob Rehm, American Association of Health Plans 237

OCR for page 238
238 FINANCING VACCINES IN THE 21ST CENTURY Janice Reichert, Tufts Center for the Study of Drug Development Robert Shoppe, Marshfield Clinic David Smith, Texas Tech University Natalie Smith, California Department of Health Services Rick Smith, Pharmaceutical Research and Manufacturers Association Dan Soland, GlaxoSmithKline Charles Stellar, American Association of Health Plans Litjen (L.r.) Tan, American Medical Association Eric Tischler, Aventis Pasteur Thomas Vernon, Merck Vaccine Division Dan Walter, American Academy of Pediatrics Piers Whitehead, VaxGen Patricia Willis, U.S. Department of Labor Lillian Woolett, Pharmaceutical Research and Manufacturers Association Elizabeth (Bitsy) York, GlaxoSmithKline Herbert Young, American Association of Family Physicians Barbara Zake, Geisinger Clinic Jennifer Zavolinsky, American Association of Health Plans Thomas Zink, GlaxoSmithKline

Representative terms from entire chapter:

aventis pasteur